• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

服用氯氮平的精神分裂症患者的唾液流速和成分:主观报告与实验室数据。

Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data.

作者信息

Ben-Aryeh H, Jungerman T, Szargel R, Klein E, Laufer D

机构信息

Laboratory of Oral Biology, Department of Oral and Maxillofacial Surgery, Rambam Medical Center, Haifa, Israel.

出版信息

Biol Psychiatry. 1996 Jun 1;39(11):946-9. doi: 10.1016/0006-3223(95)00296-0.

DOI:10.1016/0006-3223(95)00296-0
PMID:9162206
Abstract

The extent of hypersalivation was evaluated in a group of 25 schizophrenic patients on clozapine. A high prevalence of the complaint was detected by a questionnaire; up to 80% of the patients complained of hypersalivation at night. Salivary flow-rate and composition was examined in 17 patients who agreed to participate and in a matched group of healthy controls. No significant differences were detected in composition or flow-rates of resting and stimulated saliva. The salivary flow-rates in the schizophrenic patients on clozapine did not correlate with the subjective complaint of hypersalivation. Because the severity and prevalence of the complaint was higher at night, a possibility of an altered circadian rhythm of salivation might be suggested in these patients.

摘要

对一组25名服用氯氮平的精神分裂症患者的流涎程度进行了评估。通过问卷调查发现该症状的患病率很高;高达80%的患者抱怨夜间流涎。对17名同意参与的患者以及一组匹配的健康对照者进行了唾液流速和成分检测。静息和刺激唾液的成分或流速均未检测到显著差异。服用氯氮平的精神分裂症患者的唾液流速与流涎的主观主诉不相关。由于该症状在夜间的严重程度和患病率更高,因此可能提示这些患者的唾液分泌昼夜节律发生了改变。

相似文献

1
Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data.服用氯氮平的精神分裂症患者的唾液流速和成分:主观报告与实验室数据。
Biol Psychiatry. 1996 Jun 1;39(11):946-9. doi: 10.1016/0006-3223(95)00296-0.
2
Salivary flow rate in patients with schizophrenia on clozapine.服用氯氮平的精神分裂症患者的唾液流速
Clin Neuropharmacol. 2010 Jul;33(4):176-8. doi: 10.1097/WNF.0b013e3181e204e0.
3
Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.加用舒必利治疗氯氮平引起的流涎过多:初步研究。
Isr J Psychiatry Relat Sci. 2005;42(1):61-3.
4
The effect of clozapine on saliva flow rate: a pilot study.
Biol Psychiatry. 1996 Dec 1;40(11):1132-4. doi: 10.1016/S0006-3223(96)89255-9.
5
Is clonidine useful for treatment of clozapine-induced sialorrhea?可乐定对治疗氯氮平引起的流涎症有用吗?
J Psychopharmacol. 2005 Jul;19(4):426-8. doi: 10.1177/0269881105053311.
6
Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.氯氮平与氨磺必利联合使用减少副作用:病例报告及氯氮平引起流涎过多的简短综述——病例报告
Pharmacopsychiatry. 2005 Jan;38(1):38-9. doi: 10.1055/s-2005-837771.
7
Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.新西兰精神分裂症患者氯氮平处方的治疗途径与模式
Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.
8
[The clozapine-induced hypersalivation and its treatment].[氯氮平所致流涎及其治疗]
Actas Esp Psiquiatr. 1999 Nov-Dec;27(6):408-11.
9
Clozapine-induced tardive dyskinesia: a case report.氯氮平所致迟发性运动障碍:一例报告
Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29(4):633-5. doi: 10.1016/j.pnpbp.2005.01.014.
10
Trihexyphenidyl treatment of clozapine-induced hypersalivation.苯海索治疗氯氮平引起的唾液分泌过多。
Int Clin Psychopharmacol. 1997 Jul;12(4):213-5. doi: 10.1097/00004850-199707000-00005.

引用本文的文献

1
Dysphagia in schizophrenia: pathological mechanisms and treatment recommendations.精神分裂症中的吞咽困难:病理机制及治疗建议
Front Psychiatry. 2024 Sep 17;15:1448623. doi: 10.3389/fpsyt.2024.1448623. eCollection 2024.
2
Sublingual Atropine Administration for Clozapine-Induced Sialorrhea in Bipolar Disorder: A Case Report Highlighting its Efficacy, Safety Concerns and Challenges.舌下给予阿托品治疗双相障碍患者氯氮平所致流涎:病例报告强调其疗效、安全性问题和挑战。
Psychopharmacol Bull. 2024 Aug 19;54(4):124-130.
3
Salivary Flow Alteration in Patients Undergoing Treatment for Schizophrenia: Disease-Drug-Target Gene/Protein Association Study for Side-effects.
精神分裂症患者治疗期间唾液分泌变化:副作用的疾病-药物-靶基因/蛋白质关联研究
J Oral Biol Craniofac Res. 2019 Jul-Sep;9(3):286-293. doi: 10.1016/j.jobcr.2019.06.009. Epub 2019 Jun 15.
4
Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis.氯氮平诱导涎液分泌过多的治疗策略:系统评价和荟萃分析。
CNS Drugs. 2019 Mar;33(3):225-238. doi: 10.1007/s40263-019-00612-8.
5
RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials.利美布托毒素B治疗流涎症:临床试验的系统评价
J Clin Mov Disord. 2017 Jun 6;4:9. doi: 10.1186/s40734-017-0055-1. eCollection 2017.
6
Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of life.氯氮平引起的唾液分泌过多:患病率、严重程度及对生活质量影响的评估
Ther Adv Psychopharmacol. 2016 Jun;6(3):178-84. doi: 10.1177/2045125316641019. Epub 2016 Mar 30.
7
A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review.成功治疗氯氮平所致腮腺肿胀的策略:临床病例及系统评价。
Ther Adv Psychopharmacol. 2012 Dec;2(6):235-9. doi: 10.1177/2045125312455187.
8
Sialorrhea and aspiration pneumonia: a case study.流涎与吸入性肺炎:病例研究
Innov Clin Neurosci. 2013 May;10(5-6):20-7.
9
Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.抗精神病药的不良反应低钠血症:VigiBase 中的病例对照研究。
Drug Saf. 2010 Jul 1;33(7):569-78. doi: 10.2165/11532560-000000000-00000.
10
Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.肉毒毒素 B 作为一种有效且安全的治疗药物,可用于治疗抗精神病药物引起的流涎。
Psychopharmacology (Berl). 2010 Jan;207(4):593-7. doi: 10.1007/s00213-009-1689-y. Epub 2009 Oct 13.